Profarma Updates MIA License for QP Batch Release Services

Profarma is pleased to announce the successful update of its Manufacturer’s/Importer’s Authorisation (MIA) license, reinforcing our capabilities in providing Qualified Person (QP) batch release services. This update highlights our commitment in ensuring the highest levels of quality and regulatory compliance for our clients’ and tehir products.

Elevated Quality Standards:
With the updated MIA license, Profarma continues to excel in delivering QP batch release services that meet rigorous regulatory standards. Our commitment to quality is supported by cutting-edge facilities and a team of highly skilled professionals, ensuring that every product released is of the highest standard.

Enhanced Service Capabilities:
The updated MIA license enhances Profarma’s ability to provide QP batch release services. Whether clients require early registartion support or continou commercial batch release expertise, Profarma delivers tailored solutions designed to meet individual client needs efficiently.

Why Partner with Profarma for QP Batch Release Services?

  • Expert Qualified Persons: Our team of QPs brings a wealth of experience, ensuring adherence to regulatory standards and oversight of the batch release process.
  • Advanced Facility: Profarma’s state-of-the-art facility are equipped with the latest technology to support efficient and reliable batch release services.
  • Tailored Support: We offer flexible support options, from complete batch release management to specific regulatory guidance, ensuring seamless product release.

“Our recent update to the MIA license reflects Profarma’s ongoing dedication to maintaining the highest standards of quality and compliance,” said Dr. Edita Griniutė, Founder and CEO at Profarma. “We are committed to providing our clients with exceptional service and ensuring their products meet all regulatory requirements for successful market release.”

For more information about our QP batch release services and how Profarma can support your pharmaceutical products, please visit our website or contact us directly.

Contact:
info@profarma.lt

Other news